Cargando…
Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
The emergence of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Biomarkers of the therapeutic efficacy of ICIs have been extensively investigated. In this study, we aimed to analyze whether molecular p...
Autores principales: | Tada, Hiroe, Takahashi, Hideyuki, Kawabata-Iwakawa, Reika, Nagata, Yurino, Uchida, Miho, Shino, Masato, Ida, Shota, Mito, Ikko, Matsuyama, Toshiyuki, Chikamatsu, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726556/ https://www.ncbi.nlm.nih.gov/pubmed/33299117 http://dx.doi.org/10.1038/s41598-020-78741-0 |
Ejemplares similares
-
Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021) -
Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
por: Mito, Ikko, et al.
Publicado: (2021) -
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021) -
Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy
por: Takahashi, Hideyuki, et al.
Publicado: (2016) -
AKT3 is a key regulator of head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)